Biomedical Ventures

What we do

SCOUT opportunities

We select differential science and technology from prestigious academic groups and research institutions.


BUILD value

We support and accelerate the tech transfer process from academic project to company launch.


FUND projects

We engage professional investors and close on Seed & Series A rounds in Europe or the US.



What we are experts in:

Technology Transfer

  • Technology & Science Transfer strategy & mentoring
  • IP scouting and analysis
  • Support translational funding applications
  • Negotiate Technology & Science Transfer agreements


  • Entrepreneur-in-Residence program
  • Business plan
  • Incubator benchmarking, strategy and set-up
  • Scouting and managing seed funds


  • Value proposition
  • Business analysis & strategy
  • Project Valuation
  • IP & Licensing
  • Spin-out creation
  • Investment Strategies
  • Business Development

Our core activities

Transforming scientific results into biomedical companies

As a result of in-depth academic scouting process together with life sciences analysis. Chasing Science typically owns a participation as a shareholder in the ventures it builds.

Creating entrepreneurial teams

Our goal is to concentrate highly skilled talents of diverse backgrounds around each new venture that is launched.

Venture management

Chasing Science provides strategic involvement in the ventures co-founded, engaging in activities such as board advisory, market research, team management, product development, financial and legal support, fundraising and various other affairs.

this is rocket science 

this is rocket science 

this is rocket science 

this is rocket science 

this is rocket science 

Meet The Team

We're a multidisciplinary team based in Barcelona, London, Boston and Basel with a passion for science.

“Chasing Science is a place where entrepreneurial talent can grow as a team and as individuals and where scientists can get a variety of benefits from building their companies with us.”

Marc RamisFounder of Chasing Science

Marc Ramis Castelltort, PhD

Marc is passionate about creating novel biomedical ventures. Today, he is focused to launch ventures in the fields of pediatric-first platform technologies, oncology and longevity. He is a co-founder at Rejuveron Senescence Therapeutics AG, Ninevah Therapeutics Ltd and Senolytic Therapeutics Inc. Marc is a Board member or strategic advisor at Aptadel Therapeutics, Retinset Therapeutics, Cyclomed, Gate2Brain, Cebiotex and GeneTether. He is a co-founder and Partner at Chasing Science, an early-stage biomedical venture builder.

Marc was also a founder and Advisor at Tech & Business Innovation (TBI), an academic firm focused on knowledge exchange and corporate-academic partnerships. He also supported investments and strategic partnerships at Life Biosciences Inc. in Europe. Marc brings experience as advisor and board member for multiple organizations and as co-founder of several companies. Marc has implemented Entrepreneurs-in-Residence programs at several academic institutions such as IRB Barcelona. From 2010 to 2012, Marc was working for Isis Innovations/University of Oxford as an associate consultant in Spain and LATAM. From 2007 to 2011, Marc was working at Endor, a nanomedicine company based in Spain. During this period, he was R&D director (drug-delivery nano-systems for cancer therapy) and Business Development Director (launched several nanotechnology products to the cosmetic and textile markets).

Previously, Marc also worked in the pharmaceutical environment in Novartis. He also collaborated with other research institutions such as Cancer Research UK and Boston College during his academic career. Marc gained a DPhil in Biochemistry from the University of Oxford in 2006, and a Harvard Business School PLD Program in 2011. Marc also gained a M.Sc. in Chemical Engineering in 2001 and a B.Sc. in Chemistry from IQS (Barcelona) in 2000.

Venture Partner

Gonzalo Fernández-Miranda, PhD

Gonzalo is a partner at Chasing Science, where he supports the development and creation of new biomedical companies.

He is Head of Operations and Discovery of Ninevah Therapeutics, a portfolio company developing gene therapies for orphan kidney diseases; and interim Head of Operations of Aptadel Therapeutics, another portfolio company developing an RNA-based platform to treat Ewing’s sarcoma and other cancers.

Biochemist by training with a PhD in Molecular Biology, Gonzalo is specialized in RNA biology, gene therapy and molecular oncology. He is the author/co-author of 16 articles with over 800 citations. Gonzalo gained practical entrepreneurial experience thanks to the CaixaImpulse acceleration program (2017) and executive training at ESADE Business School.

Venture Partner

Pilar Puig Sàrries, PhD

I’m a doctor in molecular biology with a passion for building new projects and companies. I co-founded an NGO in 2012 (Mou) and a startup in 2014 (retail industry). Since then, I’ve been involved in the inception, acceleration and funding of startups in the health sector.
I’ve evaluated more than 150 investment opportunities and I’ve participated in the investment rounds of 16 startups that together raised more than €12M.

Where you can find us

We are launching our ventures in Barcelona, London, Boston and Basel with a passion for science.

Do you believe that science can change the world?

Looking forward to work with you


Tech Barcelona - Pier07
Via Laietana, 26
08003 Barcelona